
Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a study in Pediatrics that looked at what occurred in the wake of California's Senate Bill 277, which removed personal belief exemptions for vaccines.





